Detalhe da pesquisa
1.
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
Lancet Oncol
; 25(2): e73-e83, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38301705
2.
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.
Br J Cancer
; 130(2): 242-250, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38012381
3.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34081848
4.
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Breast Cancer Res Treat
; 203(2): 351-363, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37878152
5.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Breast Cancer Res Treat
; 203(3): 497-509, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37938495
6.
Ovarian Suppression: Early Menopause and Late Effects.
Curr Treat Options Oncol
; 25(4): 523-542, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38478329
7.
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.
J Natl Compr Canc Netw
; 21(1): 33-41.e16, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36634607
8.
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
Br J Cancer
; 127(10): 1799-1807, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36050448
9.
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.
Oncologist
; 27(9): 722-731, 2022 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35704278
10.
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.
Breast Cancer Res Treat
; 192(2): 457-462, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35076812
11.
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.
Lancet Oncol
; 22(7): e303-e313, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33891888
12.
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.
Lancet Oncol
; 22(11): e488-e500, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34735818
13.
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.
Lancet Oncol
; 22(1): e18-e28, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33387500
14.
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial.
Int J Cancer
; 148(6): 1529-1535, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33152119
15.
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 185(1): 107-116, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32951084
16.
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancer.
Eur J Clin Invest
; 51(7): e13535, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33662161
17.
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
J Natl Compr Canc Netw
; 19(2): 181-189, 2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33401235
18.
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.
Curr Oncol Rep
; 23(5): 57, 2021 03 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33763756
19.
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.
Breast Cancer Res
; 22(1): 115, 2020 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33109233
20.
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
Int J Cancer
; 147(1): 160-169, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31724170